TSE: 4523 - Eisai Co., Ltd.

Yield per half year: -9.47%
Sector: Healthcare

Eisai Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
4/10
42.59 111.03 -61.64% 26.56 +60.35%
P/S 2.43 75.03 -96.75%
P/BV 2.01 70.29 -97.14%
P/FCF 85.02 80.52 5.58%
Ev/Ebitda 19.83 76.71 -74.15%
Ev/S 2.3 72.43 -96.82%
Ev/FCF 54.8 15.5 253.61%
E/P 0.016 0.1179 -86.43%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
11.61 -78.2 -114.85% 14.65 -20.74%
ROE 4.84 -10.46 -146.32%
ROA 3.04 -10.03 -130.33%
ROIC 10.94 9.09 20.36%
ROS 5.72 -143.89 -103.98%
ROCE 5.2 2.34 121.89%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.96 1.08 81.96% 1.21 +61.78%
Nеt Debt/Ebitda -1.14 -0.3908 190.85%
Debt/Ratio 0.1213 0.1308 -7.32%
Debt/Equity 1.01 6.92 -85.35%
Debt/Net Income 3.99 -1.84 -316.43%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
4.2 2.62 60.02% 2.73 +53.63%
Number of years of dividend growth 0 1.16 -100%
DSI 0.9286 0.7238 28.29%
Average dividend growth 1.04 -10.93 -109.53%
Average percentage for 5 years 2.73 1.88 45.21%
Average percentage for payments 83.52 37.94 120.16%
Difference from average difference in sector 1.58

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
6.63 170.19 -96.1%
Growth impulse Ebitda in 5 years -47.22 101.21 -146.66%
Growth impulse Net Income in 5 years -65.17 82.55 -178.95%
Growth impulse FCF in 5 years -40.7 104.08 -139.1%
Growth impulse EPS in 5 years -91.3 127.91 -171.38%
IP Score
4.5/10

Similar companies

Astellas Pharma Inc.

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription